Literature DB >> 4971464

Potentiation of oral anticoagulant therapy by acetaminophen.

A M Antlitz, J A Mead, M A Tolentino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4971464

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  9 in total

1.  Incidence of delayed complications following percutaneous CT-guided biopsy of bone and soft tissue lesions of the spine and extremities: a 2-year prospective study and analysis of risk factors.

Authors:  Ambrose J Huang; Elkan F Halpern; Daniel I Rosenthal
Journal:  Skeletal Radiol       Date:  2012-05-22       Impact factor: 2.199

2.  Warfarin and Distalgesic interaction.

Authors:  M Orme; A Breckenridge; P Cook
Journal:  Br Med J       Date:  1976-01-24

3.  Some potential interactions between prescribed drugs and over-the-counter drug products.

Authors:  J N Turner
Journal:  Calif Med       Date:  1972-09

4.  Anticoagulant interactions.

Authors: 
Journal:  Br Med J       Date:  1971-10-16

5.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

Review 6.  Paracetamol.

Authors:  T J Meredith; R Goulding
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

7.  Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.

Authors:  Renato D Lopes; John D Horowitz; David A Garcia; Mark A Crowther; Elaine M Hylek
Journal:  Blood       Date:  2011-09-12       Impact factor: 22.113

8.  Paracetamol: a haemorrhagic risk factor in patients on warfarin.

Authors:  I Mahé; N Bertrand; L Drouet; G Simoneau; E Mazoyer; C Bal dit Sollier; C Caulin; J F Bergmann
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

Review 9.  Does paracetamol potentiate the effects of oral anticoagulants?: a literature review.

Authors:  Isabelle Mahé; Charles Caulin; Jean-François Bergmann
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.